Form 4: Marvell Technology COO Chris Koopmans Sells 6,000 Shares

Sentiment:

SEC Form 4


Marvell Technology's Chief Operating Officer, Chris Koopmans, sold 6,000 shares of common stock on May 15, 2025, at an average price of $65.1 per share, according to a Form 4 filing with the SEC.

Summary

  • Chris Koopmans, the Chief Operating Officer of Marvell Technology, Inc., sold 6,000 shares of common stock on May 15, 2025.
  • The sale was executed at a weighted average price of $65.1 per share, with individual transactions ranging from $65.00 to $65.18.
  • The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on June 17, 2024.
  • Following the transaction, Koopmans directly owns no shares and indirectly owns 92,065 shares through a family trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Comparison to Industry Standards

  • Comparing this transaction to other insider sales in the semiconductor industry, it's important to consider the size of the sale relative to Koopmans' total holdings and the company's market capitalization.
  • For example, sales by executives at companies like Nvidia (NVDA) or AMD (AMD) are often scrutinized closely due to their significant market influence.
  • The use of a 10b5-1 plan is a standard practice among executives to avoid accusations of insider trading, similar to practices at Texas Instruments (TXN) and Intel (INTC).

Stakeholder Impact

  • The sale could have a minor impact on shareholder sentiment, but given the pre-planned nature of the transaction, it's unlikely to cause significant concern.

Key Dates

DateDescription
06/17/2024Date of adoption of the 10b5-1 trading plan.
05/15/2025Date of the stock sale transaction.

Keywords

Marvell Technology, Chris Koopmans, stock sale, Form 4, 10b5-1 trading plan, insider trading, MRVL, Chief Operating Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.